JP2012524884A5 - - Google Patents

Download PDF

Info

Publication number
JP2012524884A5
JP2012524884A5 JP2012503715A JP2012503715A JP2012524884A5 JP 2012524884 A5 JP2012524884 A5 JP 2012524884A5 JP 2012503715 A JP2012503715 A JP 2012503715A JP 2012503715 A JP2012503715 A JP 2012503715A JP 2012524884 A5 JP2012524884 A5 JP 2012524884A5
Authority
JP
Japan
Prior art keywords
mmp
positive control
expression
matrix metalloproteinases
test compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012503715A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012524884A (ja
JP5330596B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/029670 external-priority patent/WO2010115031A1/en
Publication of JP2012524884A publication Critical patent/JP2012524884A/ja
Publication of JP2012524884A5 publication Critical patent/JP2012524884A5/ja
Application granted granted Critical
Publication of JP5330596B2 publication Critical patent/JP5330596B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012503715A 2009-04-01 2010-04-01 口腔用組成物の抗骨喪失および抗付着喪失作用 Expired - Fee Related JP5330596B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16568509P 2009-04-01 2009-04-01
US61/165,685 2009-04-01
PCT/US2010/029670 WO2010115031A1 (en) 2009-04-01 2010-04-01 Anti bone-loss and anti attachment-loss effects of an oral composition

Publications (3)

Publication Number Publication Date
JP2012524884A JP2012524884A (ja) 2012-10-18
JP2012524884A5 true JP2012524884A5 (enExample) 2013-07-25
JP5330596B2 JP5330596B2 (ja) 2013-10-30

Family

ID=42328354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012503715A Expired - Fee Related JP5330596B2 (ja) 2009-04-01 2010-04-01 口腔用組成物の抗骨喪失および抗付着喪失作用

Country Status (19)

Country Link
US (1) US8637266B2 (enExample)
EP (1) EP2414838B1 (enExample)
JP (1) JP5330596B2 (enExample)
CN (1) CN102365550B (enExample)
AR (1) AR076177A1 (enExample)
AU (1) AU2010232590B2 (enExample)
BR (1) BRPI1013185A2 (enExample)
CA (1) CA2757317C (enExample)
CO (1) CO6420374A2 (enExample)
DK (1) DK2414838T3 (enExample)
ES (1) ES2432864T3 (enExample)
MX (1) MX2011008438A (enExample)
MY (1) MY158406A (enExample)
PL (1) PL2414838T3 (enExample)
RU (1) RU2524629C2 (enExample)
SG (1) SG173487A1 (enExample)
TW (1) TWI405565B (enExample)
WO (1) WO2010115031A1 (enExample)
ZA (1) ZA201106054B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101745067B1 (ko) * 2014-12-31 2017-06-12 서울대학교산학협력단 치주질환 예측 시스템 및 이를 이용한 치주질환 예측 방법
KR102098624B1 (ko) * 2019-09-20 2020-04-08 서울대학교산학협력단 타액 mmp-9 및 il-8를 이용한 치주염 예측 시스템 및 이를 이용한 치주염 예측 방법

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5032386A (en) 1988-12-29 1991-07-16 Colgate-Palmolive Company Antiplaque antibacterial oral composition
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
US4894220A (en) 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
CA2176237A1 (en) 1993-11-10 1995-05-18 Richard P. Darveau Treatment of bacterially-induced inflammatory diseases
FI98961C (fi) * 1994-08-26 1997-09-10 Medix Biochemica Ab Oy Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
EP0935454B1 (de) 1996-06-12 2001-08-22 Cognis Deutschland GmbH Kosmetische und/oder pharmazeutische zubereitungen
US5998487A (en) * 1998-04-08 1999-12-07 Colgate-Palmolive Company Anti-inflammatory and antibacterial benzyl phenol agents and their use in oral compositions
JP3763075B2 (ja) * 1998-04-24 2006-04-05 サンスター株式会社 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
US6165447A (en) * 1999-06-15 2000-12-26 Colgate-Palmolive Company Synergistic antibacterial combination
WO2001048481A1 (en) 1999-12-03 2001-07-05 Baxter International Inc. Pyrogenicity test for use with automated immunoassay systems
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
WO2001078652A2 (en) 2000-04-14 2001-10-25 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
DOP2002000332A (es) * 2001-02-14 2002-08-30 Warner Lambert Co Inhibidores de piridina de metaloproteinasas de la matriz
AU2003249531A1 (en) * 2002-08-13 2004-02-25 Warner-Lambert Company Llc Azaisoquinoline derivatives as matrix metalloproteinase inhibitors
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
TW200902047A (en) 2003-02-14 2009-01-16 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
WO2005039504A2 (en) 2003-10-24 2005-05-06 Eisai Co., Ltd. Compounds and methods for treating toll-like receptor 2-related diseases and conditions
US20070212686A1 (en) 2003-12-03 2007-09-13 Whitehead Institute For Biomedical Research Use Of T-Cadherin As A Target
FI20040572A0 (fi) * 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
JP4662043B2 (ja) * 2004-09-09 2011-03-30 国立大学法人東京農工大学 歯周病発症の評価システム
CN101111288A (zh) * 2004-12-02 2008-01-23 高露洁-棕榄公司 含酚类化合物和抗氧化剂维生素和维生素衍生物的口腔护理组合物
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
JP5024506B2 (ja) * 2005-03-25 2012-09-12 ライオン株式会社 歯周組織破壊の抑制・改善剤及び口腔用組成物
RU2431845C2 (ru) 2006-01-10 2011-10-20 Колгейт-Палмолив Компани Способы модулирования рецепторов клеточных поверхностей для предотвращения или снижения воспаления
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
US8333981B2 (en) 2007-10-09 2012-12-18 Humco Holding Group, Inc. Antifungal treatment of nails
TWI481870B (zh) * 2009-04-01 2015-04-21 Colgate Palmolive Co 用於軟組織疾病診斷及作為用於口腔保健干預的標靶之蛋白質生物標記

Similar Documents

Publication Publication Date Title
US11864740B2 (en) Sample collection and preservation devices, systems and methods
Pinto et al. Clinical and microbiological effect of calcium hydroxide protection in indirect pulp capping in primary teeth.
Martinez et al. Idiopathic pulmonary fibrosis
Mawardi et al. Current understanding of the relationship between periodontal and systemic diseases
Pozhitkov et al. Towards microbiome transplant as a therapy for periodontitis: an exploratory study of periodontitis microbial signature contrasted by oral health, caries and edentulism
Huang et al. Evaluation of biomarkers for in vitro prediction of drug‐induced nephrotoxicity: comparison of HK‐2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells
Cabras et al. Age-dependent modifications of the human salivary secretory protein complex
Cesaratto et al. Specific inhibition of the redox activity of ape1/ref-1 by e3330 blocks tnf-α-induced activation of IL-8 production in liver cancer cell lines
Heng et al. Oral bacteriome and mycobiome across stages of oral carcinogenesis
Zheng et al. DNA methylation clocks for estimating biological age in Chinese cohorts
JP2013518244A5 (enExample)
BR122018069446B8 (pt) método in vitro para detectar a presença de um célula de câncer em um indivíduo
Devuyst et al. Uromodulin, kidney function, cardiovascular disease, and mortality
Zhou et al. Advances in DNA/RNA detection using nanotechnology
JP2016520611A5 (enExample)
TWI481870B (zh) 用於軟組織疾病診斷及作為用於口腔保健干預的標靶之蛋白質生物標記
JP2012524884A5 (enExample)
JP2011518338A5 (enExample)
JP2016531843A5 (enExample)
JP2015523364A5 (enExample)
WO2011069058A8 (en) Methods for predicting and treating a sterile inflammation and discriminating between sterile and infective inflammation
RU2011144028A (ru) Эффекты пероральной композиции против потери костной массы и потери прикрепления
Zhang et al. Saliva diagnostics for oral diseases
Grek et al. S-glutathionylation of buccal cell proteins as biomarkers of exposure to hydrogen peroxide
Sheng et al. Development and application of antibody microarray for lymphocystis disease virus detection in fish